PLA2R1 and tuberculosis: This is supported by the observed anti-PLA2R antibody titers trend: 145.9 RU/mL at TB diagnosis, with a progressive decline to <2 RU/mL over 24 months following anti-TB treatment, mirroring clinical remission.